Home
Live Updates
IRONMAN Galvanizes Case for IV Iron Repletion in Heart Failure : comparemela.com
IRONMAN Galvanizes Case for IV Iron Repletion in Heart Failure
The trial missed its primary endpoint, but makes unique contributions; many see it as further evidence that the treatment helps iron-deficient patients with heart failure.
Related Keywords
United Kingdom ,
United States ,
Philadelphia ,
Pennsylvania ,
Boston ,
Massachusetts ,
Minnesota ,
University Of Pennsylvania ,
Chicago ,
Illinois ,
London ,
City Of ,
American ,
Gregoryd Lewis ,
Vifor Pharma ,
Kiran Musunuru ,
Paul Kalra ,
Theresa Mcdonagh ,
Amgen ,
American Heart Association ,
School Of Cardiovascular Sciences ,
King College Hospital ,
Boehringer Ingelheim ,
American Heart Association Scientific Sessions ,
University Of Glasgow ,
Perelman School Of Medicine ,
Novartis ,
Pfizer ,
Astrazeneca ,
European Society Of Cardiology ,
Portsmouth Hospitals University ,
Scientific Sessions ,
Mass General Brigham ,
Perelman School ,
College Hospital ,
Cardiovascular Sciences ,
Rate Ratios ,
Usual Care ,
Minnesota Living ,
Heart Failure Questionnaire ,
European Society ,
Verve Therapeutics ,
American Regent ,
Heart Association Scientific Sessions ,
Breaking Science ,
Breakthrough Strategies ,
Randomized Trial ,
Intravenous Ferric Derisomaltose ,
Heart Failure ,
Reduced Ejection ,
Presented November ,
Iron Deficiency Anemia ,
Heart ,
Iron Replacement Therapy ,
Cardiovascular Imaging ,
Ardiac Imaging ,
V Imaging ,
Intravenous Iv ,
Intravenous ,
Tv ,
Hospitals ,
Ejection Fraction Ef ,
Eft Ventricular Ejection Fraction Lvef ,
Uk National Health Service ,
United Kingdom National Health Service ,
K Nhs ,
Dhs ,
National Health Service ,
Quality Of Life ,
Pol ,
Ealth Related Quality Of Life ,
Ealth Rela ,
comparemela.com © 2020. All Rights Reserved.